Publisher: Bentham Science Publishers
E-ISSN: 1875-5348|20|8|930-938
ISSN: 1385-2728
Source: Current Organic Chemistry, Vol.20, Iss.8, 2016-04, pp. : 930-938
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
A3 adenosine receptors (ARs) have long been viewed as potential therapeutic targets due to their association with a variety of pathophysiological processes. Development of potent and selective A3AR nucleoside ligands has been an area of interest of medicinal chemists since last two decades. Various prime modifications made on N6 and C-2 position of the adenosine moiety has led to the discovery of some of the most efficacious A3AR ligands. This review is an account of the development of 4'-thionucleosides as A3AR agonists and antagonists by various chemical modifications on the thionucleoside template.
Related content
By Luongo Livio Petrelli Riccardo Gatta Luisa Giordano Catia Guida Francesca Vita Patrizia Franchetti Palmarisa Grifantini Mario de Novellis Vito Cappellacci Loredana Maione Sabatino
Molecules, Vol. 17, Iss. 12, 2012-11 ,pp. :